Target intelligence / Profile preview

Insulin-like 4 pseudogene

Molecular classification: Pseudogene

Overview

The Insulin-like 4 pseudogene (ENSG00000237553) is a genomic element that resembles the sequence of the functional insulin-like 4 gene but does not encode a functional protein product[3]. Pseudogenes, such as this, are considered non-functional segments of DNA arising from gene duplication or retrotransposition events, and generally lack biological activity or therapeutic relevance[1].

Other names: Insulin-like 4 (Placenta) pseudogeneINSL4 pseudogene

Beyond the preview

Go deeper on Insulin-like 4 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Insulin-like 4 pseudogene.

Explore the full profile